about
Booster dose vaccination for preventing hepatitis BBooster dose vaccination for preventing hepatitis BLessons learnt over two decades of vaccination against hepatitis B in ItalyImmunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel diseaseHepatitis B and the need for a booster doseContribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccineHepatitis B response of premature infants after primary and booster immunisation with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/haemophilus influenzae type B vaccine.Hepatitis B virus: where do we stand and what is the next step for eradication?Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges.Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccinationCompliance with hepatitis B vaccination among adult males with sexually transmitted infectionsDurability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.Raising expectations for subunit vaccineAnti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society.Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 yearsThe persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancyThe one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administrationBivalent inactivated hepatitis A and recombinant hepatitis B vaccine.Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed childrenLong-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.Plant-based vaccines against human hepatitis B virus.The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.Old and new adjuvants for hepatitis B vaccines.The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.A comparison of hepatitis B seroepidemiology in ten European countries.Insulin resistance increases loss of antibody to hepatitis B surface antigen in nondiabetic healthy adults.Principles of Vaccination.Hepatitis B infections.Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil.Hepatitis B immunisation in Britain: time to change?Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?Hepatitis B virus vaccination of blood donors--what costs may be expected?
P2860
Q24236587-163843BA-A9B8-40DC-B5E3-E3BC8E10B297Q26471510-087D407C-678E-4D9B-BA58-B9B3CEEAA751Q26770673-340A876B-50DD-4DFA-9422-4629229AAC9AQ26777330-41BBF176-1D86-4B97-BECF-3DB40A556246Q28239937-CA55A7B7-4FF2-4B28-9439-326900F8B103Q28393904-A69F2B6D-DD2C-42DF-B6F9-6FB49A05F02BQ33786286-E57EC1A7-1C7A-48D8-91E0-D1F7DE72FDFBQ33958764-605A58E2-8D2A-4529-A9DB-CDADEE7FC76BQ34074115-127E6ABD-4E9C-40C1-866D-196B91EBECC2Q34077801-E2EF7F59-3A78-40BD-80E5-331432B06535Q34425952-3934A17F-5671-4F02-BFE3-0E1C5900E70BQ34628828-2D846073-CB3F-4CD7-8318-81D04CF42A86Q35055166-92809DA8-11FF-4086-B9CC-CE95C4B4FE72Q35441596-E5FEE347-1C56-4A10-814C-D687C1E0EF9FQ35452705-D0331810-1A9E-4DB4-9748-526E4A646368Q35507370-2B975F92-DBEF-4511-B2D1-BB1DEC5FE088Q35539786-F9D7283D-24D9-492A-96A4-FA7F81D61F4FQ35577825-DF1EEF45-C6C9-43CC-B2CF-7383C2F67DE9Q35886424-FE3F0678-CFBF-4888-8981-1F7FA4CA2924Q35886836-7A6252CC-5132-495D-8FB7-808A5BAF74D6Q36138640-4AB2F356-3E3F-4270-9949-7C8FD9EDD0C2Q36365279-48B71FEC-8AAC-4072-9EC0-E8D4186391B5Q36391894-6FC36F6F-D2AF-4384-85DC-3E9A2C137FADQ36748019-688DE5ED-15E4-4049-A252-46FD3E2A5D63Q37123438-9A19EB59-65B8-4BB1-B066-19F94E25149AQ37521922-01CA8328-D3B9-43B8-A320-FA680C12D1B9Q37530077-4842DEA7-2EDC-401D-BF53-80DDB341A262Q37776722-E63F897C-E440-4A11-821C-3156972AA2CCQ38111651-5D6E5C4B-7753-4841-ACCD-336DF7D549B3Q38293586-4A8D1C48-5202-482C-B632-72C7A8A2B684Q38650844-56AB7B26-5251-4573-8A04-117F460BCCBBQ40016555-D9819720-89E7-4E87-907A-BE918FEF92B5Q40471500-BAC4F468-C347-475F-AC4E-E2C264A4D004Q40715837-3D377E1A-3C37-4D79-B59F-0FA093907D16Q42419156-74E3BD5D-2C62-457C-8BB4-8BD46B3BF8EAQ43037024-D4AE0594-7DD6-4375-8EED-F5024A06444CQ43219148-1A1E9964-598C-46E5-BE50-6667A0135C0FQ44525165-D1CD27AD-1378-486A-ADD1-3F0B5BFCE133Q45273524-AB82CC46-DE5C-4774-8FFF-83D90A1BAF52Q45472575-F2CC8560-8471-4791-B475-347E0B658A5E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis B vaccine -- do we need boosters?
@ast
Hepatitis B vaccine -- do we need boosters?
@en
type
label
Hepatitis B vaccine -- do we need boosters?
@ast
Hepatitis B vaccine -- do we need boosters?
@en
prefLabel
Hepatitis B vaccine -- do we need boosters?
@ast
Hepatitis B vaccine -- do we need boosters?
@en
P2860
P1476
Hepatitis B vaccine -- do we need boosters?
@en
P2093
Banatvala JE
Van Damme P
P2860
P356
10.1046/J.1365-2893.2003.00400.X
P577
2003-01-01T00:00:00Z